Wavegate Corporation is a medical technology company engaged in development of internally-generated intellectual property (IP) pertaining to neuromodulation. Our patented StimuLux (TM) technology is uniquely poised to enhance the pain-relief and minimize side-effects from spinal cord stimulation (SCS) used for the treatment of chronic pain.
Approximately 68,000 patients per year in the United States receive spinal cord stimulators for the treatment of chronic pain which is refractory to medical and/or surgical management. Spinal Cord Stimulators apply electrical signals to the spinal cord via an electrode array implanted within the spine. These electrical signals interfere with transmission of pain signals to the brain, hence decreasing the severity of the perceived pain.
Because the spinal cord position shifts relative to the electrode array as a patient moves or changes posture, a fixed stimulation amplitude may result in noxious overstimulation or loss of efficacy through understimulation. Thus, optimal pain relief is achieved through real-time modulation of the electrical stimulation in response to spinal cord motion, a process known as adaptive neuromodulation. StimuLux (TM) optical sensing technology provides real-time, efficient, direct measurement of spinal cord position relative to the sensor array, allowing effective adaptive neuromodulation in response to real life activities.
Approximately 68,000 patients per year in the United States receive spinal cord stimulators for the treatment of chronic pain which is refractory to medical and/or surgical management. Spinal Cord Stimulators apply electrical signals to the spinal cord via an electrode array implanted within the spine. These electrical signals interfere with transmission of pain signals to the brain, hence decreasing the severity of the perceived pain.
Because the spinal cord position shifts relative to the electrode array as a patient moves or changes posture, a fixed stimulation amplitude may result in noxious overstimulation or loss of efficacy through understimulation. Thus, optimal pain relief is achieved through real-time modulation of the electrical stimulation in response to spinal cord motion, a process known as adaptive neuromodulation. StimuLux (TM) optical sensing technology provides real-time, efficient, direct measurement of spinal cord position relative to the sensor array, allowing effective adaptive neuromodulation in response to real life activities.
Location: United States, Louisiana, Lake Charles
Employees: 1-10
Total raised: $26M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | New Orlean... | neworleans... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.12.2024 | Series A | $26M | - |
Mentions in press and media 5
| Date | Title | Description |
| 13.12.2024 | Wavegate's $26 Million Leap: A New Dawn in Pain Management Technology | In the world of chronic pain management, innovation is a lifeline. Wavegate Corporation, a trailblazer in neuromodulation technology, has just secured a $26 million Series A funding round. This financial boost, led by UCEA Capital Partners,... |
| 13.12.2024 | Wavegate receives $26M for neuromodulation technology for chronic pain | Photo: William Geddes/Getty Images Wavegate Corporation, a company that makes neuromodulation technology for chronic pain management, has secured $26 million in a Series A funding round led by UCEA Capital Partners Ltd. WHAT IT DOES The Lou... |
| 12.12.2024 | Wavegate: Neuromodulation Technology Company Reveals $26 Million (Series A) Round | Wavegate, a pioneering developer of neuromodulation technology for chronic pain management, announced it has secured a lead investor in their $26 million Series A funding round led by UCEA Capital Partners, a London-based investment firm. T... |
| 11.12.2024 | Wavegate Corporation Raises $26M in Series A Funding | Wavegate Corporation, a Lake Charles, LA-based developer of neuromodulation technology for chronic pain management, raised $26M in Series A funding. The round was led by UCEA Capital Partners. The company intends to use the funds to acceler... |
| - | Wavegate | “Wavegate's Ellipse spinal cord stimulator platform with StimuLux optical reflectometry offers the most advanced solution for closed-loop SCS treatment of chronic pain. StimuLux offers plug-and-play motion-responsive dosing for paresthesia-... |